Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 68289-68290 [2021-26111]
Download as PDF
<![CDATA[
68289
Federal Register / Vol. 86, No. 228 / Wednesday, December 1, 2021 / Notices
Affected public: Key stakeholder
groups involved in specific Federal and
State-administered programs; state or
local government officials; participants
in specific Federal and State-
administered programs or similar
comparison groups; and experts in
fields pertaining to specific Federal and
State research and programs.
USDS estimates that the total burden
of this information collection over a
three-year period will be 20,676 hours.
USDS estimates that the annual burden
of this information collection is as
follows, with one response per
respondent:
ESTIMATED ANNUAL BURDEN
Number of
respondents
lotter on DSK11XQN23PROD with NOTICES1
Type of collection
Minutes per
response
Total hours
Pre-study self-identification questionnaire ...................................................................................
Unmoderated comment cards/complaint forms ...........................................................................
Unmoderated qualitative user experience questionnaire ............................................................
Unmoderated information architecture evaluative methods ........................................................
Unmoderated content evaluative methods ..................................................................................
Long-term behavior and experience studies ...............................................................................
Focus groups ...............................................................................................................................
User research studies ..................................................................................................................
Program assessment questionnaires ..........................................................................................
10,000
2,500
2,500
800
800
50
100
2,500
300
5
5
30
60
60
300
60
60
30
833
208
1,250
800
800
250
100
2,500
150
Total ......................................................................................................................................
19,550
610
6,892
Request for Comments
In compliance with the requirements
of Section 3506(c)(2)(A) of the PRA,
USDS is soliciting public comment on
the specific aspects of the information
collection described above. Copies of
the proposed collection of information
can be obtained by writing to pra@
usds.gov. All requests should be
identified by the title of the information
collection.
USDS specifically requests comments
on (a) Whether the collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the collection of
information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; (d) ways to
minimize the burden of the collection of
information on respondents, including
through the use of automated collection
techniques or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install, and utilize technology
and systems for the purpose of
collecting, validating, and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
VerDate Sep<11>2014
17:08 Nov 30, 2021
Jkt 256001
the collection of information; and to
transmit or otherwise disclose the
information. Consideration will be given
to comments and suggestions submitted
within 60 days of this publication.
An agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a currently valid OMB
control number.
Authority: USDS is undertaking the
collections at the discretion of the
agency, and under the general authority
of 44 U.S.C. 3504 and the Information
Technology Oversight and Reform
(ITOR) fund, as provided by the
Consolidated Appropriations Act, 2021,
Division E, Title II, 116 H.R. 133.
Mina Hsiang,
Administrator, United States Digital Service.
[FR Doc. 2021–26081 Filed 11–30–21; 8:45 am]
BILLING CODE 3110–05–P
NATIONAL SCIENCE FOUNDATION
Notice of Permits Issued Under the
Antarctic Conservation Act of 1978
National Science Foundation.
Notice of permits issued.
AGENCY:
ACTION:
The National Science
Foundation (NSF) is required to publish
notice of permits issued under the
Antarctic Conservation Act of 1978.
This is the required notice.
FOR FURTHER INFORMATION CONTACT:
Polly Penhale, ACA Permit Officer,
Office of Polar Programs, National
Science Foundation, 2415 Eisenhower
Avenue, Alexandria, VA 22314; 703–
292–8030; email: ACApermits@nsf.gov.
SUPPLEMENTARY INFORMATION: On
October 27, 2021, the National Science
SUMMARY:
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
Foundation published a notice in the
Federal Register of permit applications
received. The permits were issued on
November 26, 2021, to:
1. Nicole Abbott, Wilderness Travel
Permit No. 2021–014
2. Walter Barinaga, Crystal Destination
Experiences Permit No. 2021–019
Erika N. Davis,
Program Specialist, Office of Polar Programs.
[FR Doc. 2021–26124 Filed 11–30–21; 8:45 am]
BILLING CODE 7555–01–P
NUCLEAR REGULATORY
COMMISSION
Advisory Committee on the Medical
Uses of Isotopes: Meeting Notice
U.S. Nuclear Regulatory
Commission.
ACTION: Notice of meeting.
AGENCY:
The U.S. Nuclear Regulatory
Commission (NRC) will convene a
meeting of the Advisory Committee on
the Medical Uses of Isotopes (ACMUI)
on December 15, 2021 to discuss the
NRC staff’s draft Alpha Tau Alpha
DartTM Manual Brachytherapy Licensing
Guidance and the ACMUI
Subcommittee on Alpha Dart draft
report on the proposed draft licensing
guidance; the NRC staff’s draft
additional licensing considerations
memo for CivaTech Oncology Inc.’s
CivaDermTM and the ACMUI
Subcommittee ACMUI Subcommittee
on Civaderm draft report on the
proposed draft memo; the NRC staff’s
draft revision of Regulatory Guide 8.39,
‘‘Release of Patients Administered
Radioactive Material and the ACMUI
Subcommittee on Regulatory Guide
SUMMARY:
E:\FR\FM\01DEN1.SGM
01DEN1
68290
Federal Register / Vol. 86, No. 228 / Wednesday, December 1, 2021 / Notices
8.39, ‘‘Release of Patients Administered
Radioactive Material’’ draft report on
the proposed draft revision of the
regulatory guide. The meeting agenda is
subject to change. The current agenda
and any updates will be available on the
ACMUI’s Meetings and Related
Documents web page at https://
www.nrc.gov/reading-rm/doccollections/acmui/meetings/2021.html
or by emailing Mr. Don Lowman at the
contact information below.
Date
Link: https://teams.microsoft.com/l/meetup-join/19%3ameeting_ODUxNGM4MjgtNjEzMi00ZjM5LTliZDY
tODliYTgyODQ1ZTE1%40thread.v2/0?context=%7b%22Tid%22%3a%22e8d01475-c3b5-436a-a065-5def4c64f52e
%22%2c%22Oid%22%3a%2246306069-534e-4ca8-95c1-728fcf94561d%22%7d.
Call in number (audio only): +1 301–576–2978 (Silver Spring, MD, U.S.)
Phone Conference ID: 694 987 19#.
lotter on DSK11XQN23PROD with NOTICES1
Public Participation: The meeting will
be held as a webinar using Microsoft
Teams. Any member of the public who
wishes to participate in any open
sessions of this meeting should click on
the link above to join the meeting. It is
recommended that attendees should
login ten minutes prior to ensure they
can properly connect to the meeting.
Members of the public should also
monitor the NRC’s Public Meeting
Schedule at https://www.nrc.gov/pmns/
mtg for any meeting updates. If there are
any questions regarding the meeting,
persons should contact Mr. Lowman
using the information below.
FOR FURTHER INFORMATION CONTACT: Mr.
Don Lowman, email: Donald.Lowman@
nrc.gov, telephone: 301–415–5452.
SUPPLEMENTARY INFORMATION:
Conduct of the Meeting
Darlene F. Metter, M.D. will chair the
meeting. Dr. Metter will conduct the
meeting in a manner that will facilitate
the orderly conduct of business. The
following procedures apply to public
participation in the meeting:
1. Persons who wish to provide a
written statement should submit an
electronic copy to Mr. Lowman using
the contact information listed above. All
submittals must be received by the close
of business on December 10, 2021, three
business days before the meeting, and
must pertain to the topics on the agenda
for the meeting.
2. Questions and comments from
members of the public will be permitted
during the meeting, at the discretion of
the ACMUI Chairman.
3. The draft transcript and meeting
summary will be available on ACMUI’s
website https://www.nrc.gov/readingrm/doc-collections/acmui/meetings/
2021.html on or about January 21, 2022.
4. Persons who require special
services, such as those for the hearing
impaired, should notify Mr. Lowman of
their planned participation.
This meeting will be held in
accordance with the Atomic Energy Act
of 1954, as amended (primarily Section
161a); the Federal Advisory Committee
17:08 Nov 30, 2021
ADDRESSES:
Webinar information (Microsoft Teams)
December 15, 2021 .................................
VerDate Sep<11>2014
The teleconference meeting will
be held on Wednesday, December 15,
2021, from 2:00 p.m. to 4:00 p.m.
Eastern Standard Time.
DATES:
Jkt 256001
Act (5 U.S.C. App); and the
Commission’s regulations in title 10 of
the Code of Federal Regulations, Part 7.
Dated at Rockville, Maryland, this 24th day
of November, 2021.
For the U.S. Nuclear Regulatory
Commission.
Russell E. Chazell,
Federal Advisory Committee Management
Officer.
[FR Doc. 2021–26111 Filed 11–30–21; 8:45 am]
BILLING CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
[Docket No. 50–7513; NRC–2021–0193]
Kairos Power, LLC
Nuclear Regulatory
Commission.
ACTION: Construction permit
application; acceptance for docketing.
AGENCY:
The U.S. Nuclear Regulatory
Commission (NRC) staff accepts and
dockets an application for a
construction permit for the Hermes test
reactor to be built in Oak Ridge,
Tennessee.
SUMMARY:
This action becomes effective on
November 29, 2021.
ADDRESSES: Please refer to Docket No.
50–7513 or Docket ID NRC–2021–0193
when contacting the NRC about the
availability of information regarding this
document. You may obtain publicly
available information related to this
document using any of the following
methods:
• Federal Rulemaking Website: Go to
https://www.regulations.gov and search
for Docket ID NRC–2021–0193. Address
questions about Docket IDs in
Regulations.gov to Stacy Schumann;
telephone: 301–415–0624; email:
Stacy.Schumann@nrc.gov. For technical
questions, contact the individuals listed
in the FOR FURTHER INFORMATION
CONTACT section of this document.
• NRC’s Agencywide Documents
Access and Management System
DATES:
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
(ADAMS): You may obtain publicly
available documents online in the
ADAMS Public Documents collection at
https://www.nrc.gov/reading-rm/
adams.html. To begin the search, select
‘‘Begin Web-based ADAMS Search.’’ For
problems with ADAMS, please contact
the NRC’s Public Document Room (PDR)
reference staff at 1–800–397–209, 301–
415–4737, or by email to
PDR.Resource@nrc.gov. The ADAMS
accession number for each document
referenced (if it is available in ADAMS)
is provided the first time that it is
mentioned in the SUPPLEMENTARY
INFORMATION section.
• NRC’s PDR: You may examine and
purchase copies of public documents,
by appointment, at the NRC’s PDR,
Room P1 B35, One White Flint North,
11555 Rockville Pike, Rockville,
Maryland 20852. To make an
appointment to visit the PDR, please
send an email to PDR.Resource@nrc.gov
or call 1–800–397–4209 or 301–415–
4737, between 8:00 a.m. and 4:00 p.m.
(ET), Monday through Friday, except
Federal holidays.
• NRC’s Public Website: The
construction permit application is
available under the NRC’s Hermes
Construction Permit Application public
website at https://www.nrc.gov/reactors/
non-power/kairos-hermes.html.
FOR FURTHER INFORMATION CONTACT:
Benjamin Beasley, Office of Nuclear
Reactor Regulation, U.S. Nuclear
Regulatory Commission, Washington,
DC 20555–0001; telephone: 301–415–
2062; email: Benjamin.Beasley@nrc.gov.
SUPPLEMENTARY INFORMATION:
I. Discussion
On September 29, 2021, Kairos Power
LLC (Kairos) filed, pursuant to Part 50
of title 10 of the Code of Federal
Regulations (10 CFR), ‘‘Domestic
Licensing of Production and Utilization
Facilities,’’ the first part of an
application (ADAMS Package Accession
No. ML21272A375) for a construction
permit for the Hermes test reactor (a
‘‘testing facility’’ as defined in 10 CFR
50.2), which would be located in Oak
E:\FR\FM\01DEN1.SGM
01DEN1
]]>Agencies
[Federal Register Volume 86, Number 228 (Wednesday, December 1, 2021)]
[Notices]
[Pages 68289-68290]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-26111]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a
meeting of the Advisory Committee on the Medical Uses of Isotopes
(ACMUI) on December 15, 2021 to discuss the NRC staff's draft Alpha Tau
Alpha DartTM Manual Brachytherapy Licensing Guidance and the
ACMUI Subcommittee on Alpha Dart draft report on the proposed draft
licensing guidance; the NRC staff's draft additional licensing
considerations memo for CivaTech Oncology Inc.'s CivaDermTM
and the ACMUI Subcommittee ACMUI Subcommittee on Civaderm draft report
on the proposed draft memo; the NRC staff's draft revision of
Regulatory Guide 8.39, ``Release of Patients Administered Radioactive
Material and the ACMUI Subcommittee on Regulatory Guide
[[Page 68290]]
8.39, ``Release of Patients Administered Radioactive Material'' draft
report on the proposed draft revision of the regulatory guide. The
meeting agenda is subject to change. The current agenda and any updates
will be available on the ACMUI's Meetings and Related Documents web
page at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2021.html or by emailing Mr. Don Lowman at the contact information
below.
DATES: The teleconference meeting will be held on Wednesday, December
15, 2021, from 2:00 p.m. to 4:00 p.m. Eastern Standard Time.
ADDRESSES:
------------------------------------------------------------------------
Webinar information (Microsoft
Date Teams)
------------------------------------------------------------------------
December 15, 2021................. Link: https://teams.microsoft.com/l/meetup-join/19%3ameeting_ODUxNGM4MjgtNjEzMi00ZjM5LTliZDYtODliYTgyODQ1ZTE1%40thread.v2/0?context=%7b%22Tid%22%3a%22e8d01475-c3b5-436a-a065-5def4c64f52e%22%2c%22Oid%22%3a%2246306069-534e-4ca8-95c1-728fcf94561d%22%7d.
Call in number (audio only): +1 301-
576-2978 (Silver Spring, MD, U.S.)
Phone Conference ID: 694 987 19#.
------------------------------------------------------------------------
Public Participation: The meeting will be held as a webinar using
Microsoft Teams. Any member of the public who wishes to participate in
any open sessions of this meeting should click on the link above to
join the meeting. It is recommended that attendees should login ten
minutes prior to ensure they can properly connect to the meeting.
Members of the public should also monitor the NRC's Public Meeting
Schedule at https://www.nrc.gov/pmns/mtg for any meeting updates. If
there are any questions regarding the meeting, persons should contact
Mr. Lowman using the information below.
FOR FURTHER INFORMATION CONTACT: Mr. Don Lowman, email:
[email protected], telephone: 301-415-5452.
SUPPLEMENTARY INFORMATION:
Conduct of the Meeting
Darlene F. Metter, M.D. will chair the meeting. Dr. Metter will
conduct the meeting in a manner that will facilitate the orderly
conduct of business. The following procedures apply to public
participation in the meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to Mr. Lowman using the contact information listed
above. All submittals must be received by the close of business on
December 10, 2021, three business days before the meeting, and must
pertain to the topics on the agenda for the meeting.
2. Questions and comments from members of the public will be
permitted during the meeting, at the discretion of the ACMUI Chairman.
3. The draft transcript and meeting summary will be available on
ACMUI's website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2021.html on or about January 21, 2022.
4. Persons who require special services, such as those for the
hearing impaired, should notify Mr. Lowman of their planned
participation.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily Section 161a); the Federal Advisory
Committee Act (5 U.S.C. App); and the Commission's regulations in title
10 of the Code of Federal Regulations, Part 7.
Dated at Rockville, Maryland, this 24th day of November, 2021.
For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2021-26111 Filed 11-30-21; 8:45 am]
BILLING CODE 7590-01-P
